Testing Sivelestat Sodium and Dexamethasone for Severe ARDS
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests a combination of two medicines (Sivelestat Sodium and Dexamethasone) to see if they can help people with severe lung injury (ARDS) who need a breathing machine. It is for patients whose condition has just worsened and who are on a ventilator early in their illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe ARDS (a serious lung injury) that has recently worsened
- You are on a breathing tube and ventilator within 72 hours (3 days) of the ARDS starting
- You are not pregnant or breastfeeding
- You do not have severe heart disease, advanced cancer, or a terminal illness
- You have not signed a Do Not Resuscitate (DNR) order or decided to stop treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding a type of steroid (glucocorticoid) to standard treatment helps people on a breathing machine recover from severe lung failure (ARDS). It compares different doses to see which works best.
This trial tests a new drug called LEAF-4L6715 to see if it helps people with severe acute respiratory distress syndrome (ARDS), a serious lung condition. If you are on a breathing machine and meet the criteria below, you may be able to join.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
This trial tests if bevacizumab can help people with ARDS (a serious lung condition) breathe better. It is for patients with mild, moderate, or severe ARDS who are already in the hospital.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.